Generic Name and Formulations:
Fluorescein (as sodium) 100mg/mL (10%); soln for IV inj; preservative-free.
Alcon Laboratories, Inc.
Indications for FLUORESCITE:
Diagnostic angiography or angioscopy of the retina and iris vasculature.
Give by IV inj rapidly into the antecubital vein (normally 1mL/sec). 500mg (5mL). Highly sensitive imaging system (eg, scanning laser ophthalmoscope): reduce dose to 2mL.
Give by IV inj rapidly into the antecubital vein (normally 1mL/sec). 7.7mg/kg; max 500mg (5mL).
History of allergy. Bronchial asthma. Avoid extravasation; severe local tissue damage can result. Pregnancy. Nursing mothers: discontinue for ≥4 days after inj (pump and discard the milk during this period).
Skin and urine discoloration, nausea, vomiting, GI distress, hypersensitivity reactions, headache, thrombophlebitis; rare: cardiopulmonary reactions, convulsions, syncope.
Single use vial (5mL)—1
Sign Up for Free e-newsletters
- Study Finds Association Between Folate Intake and Risk of Cutaneous Melanoma
- Qualitative Analysis of Myeloma Patients' Experience Following Hematopoietic Stem Cell Transplant
- Melanoma Outcomes Improved With Nivolumab Alone or Plus Ipilimumab
- Involved-Field Radiotherapy Plus Chemotherapy Prolonged PFS in Follicular Lymphoma
- Patient Fears of Placebo Use in Clinical Trials
- Implementing an Ambulatory Adherence Program May Improve Oral Anticancer Medications Compliance
- Exercise Habits Influence Mortality in Adult Survivors of Childhood Cancer
- Managing Dyspnea With Fentanyl in Patients With Cancer at End of Life
- CALM: A Depression Intervention for Cancer Patients at the End of Life
- High BMI Among Premenopausal Women May Improve Risk for Breast Cancer
- Genetic Link Between Depression and Breast Cancer Remains Unclear
- Bariatric Surgery Reduced Risk of Some Cancers in Obese Patients
- Bleeding Disorder Treatments: Hemophilia A
- Guideline Recommendations Offer No OS Benefit for Younger Patients With Rectal Cancer
- Bleeding Disorder Treatments: von Willebrand Disease
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|